Breakthrough or Band-Aid? A Critical, Evidence-Based Look at Benefits, Risks, and Natural Alternatives Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide and tirzepatide, have rapidly transformed the treatment of obesity and type 2 diabetes. Originally developed for glycemic control, these medications are now widely used for weight loss, appetite suppression, and cardiometabolic improvement. While clinicalContinue reading “GLP-1 Medications: Benefits vs Risks Explained”
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Restorative Source 